Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PROMO.ST
- Price
- -
- Stock movement up
- +0.10 (0.98%)
- Company name
- Promore Pharma AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 27.49B
- Ent value
- 27.49B
- Price/Sales
- 106126.19
- Price/Book
- 15617.43
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -95.39%
- 3 year return
- -69.86%
- 5 year return
- -61.21%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
PROMO.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 106126.19 |
| Price to Book | 15617.43 |
| EV to Sales | 106123.01 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 2.67B |
| EPS (TTM) | -0.35 |
| FCF per share (TTM) | -0.72 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 259.00K |
| Gross profit (TTM) | -11.60M |
| Operating income (TTM) | -21.46M |
| Net income (TTM) | -21.50M |
| EPS (TTM) | -0.35 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -4477.99% |
| Operating margin (TTM) | -8286.87% |
| Profit margin (TTM) | -8301.54% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.89M |
| Net receivables | 0.00 |
| Total current assets | 4.82M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 4.82M |
| Accounts payable | 975.00K |
| Short/Current long term debt | 714.00K |
| Total current liabilities | 2.35M |
| Total liabilities | 3.06M |
| Shareholder's equity | 1.76M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -22.16M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -43.70M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -1221.65% |
| Return on Assets | -445.99% |
| Return on Invested Capital | -869.08% |
| Cash Return on Invested Capital | -1766.17% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| PROMO.ST | S&P500 | |
| Current price drop from All-time high | -99.47% | -0.21% |
| Highest price drop | -99.65% | -56.47% |
| Date of highest drop | 13 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -64.56% | -11.07% |
| Avg time to new high | 169 days | 12 days |
| Max time to new high | 1463 days | 1805 days |
COMPANY DETAILS
Marketcap
27.49B
Marketcap category
Large-cap
Description
Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which has completed Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is headquartered in Solna, Sweden.
Employees
1
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found